LA JOLLA PHARMACEUTICAL CO (LJPC)
US5034596040 - Common Stock
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 48.34M | 46.67M | 21.20M | 87.80M | 172.60M | |||
| Marketable Securities | 323.00K | N/A | N/A | N/A | N/A | |||
| Receivables | 5.93M | 8.61M | 5.80M | 3.00M | 1.40M | |||
| Inventories | 8.30M | 6.28M | 6.00M | 2.20M | 2.00M | |||
| Other Current Assets | 3.47M | 5.76M | 3.40M | 4.50M | 5.10M | |||
| Total Current Assets | 66.36M | 67.31M | 36.50M | 97.50M | 181.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 297.00K | 431.00K | 800.00K | 33.90M | 22.30M | |||
| Goodwill | 20.12M | 20.12M | 20.10M | N/A | N/A | |||
| Intangibles | 12.54M | 13.32M | 14.90M | N/A | N/A | |||
| Other Non-Current Assets | 40.00K | 40.00K | 0.00 | 900.00K | 900.00K | |||
| Total Non-Current Assets | 33.00M | 33.91M | 35.70M | 34.70M | 23.20M | |||
| TOTAL ASSETS | 99.37M | 101.23M | 72.20M | 132.20M | 204.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 2.33M | N/A | N/A | N/A | |||
| Accrued Expenses | 11.22M | 10.18M | 9.60M | 20.40M | 16.00M | |||
| Accounts Payable | 2.13M | 2.28M | 2.80M | 4.20M | 8.60M | |||
| Other Current Liabilities | 3.15M | 2.85M | N/A | 0.00 | 1.40M | |||
| Total Current Liabilities | 16.49M | 17.64M | 12.30M | 24.60M | 25.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 152.34M | 150.33M | 148.00M | 163.70M | 142.40M | |||
| Total Non-Current Liabilities | 152.34M | 150.33M | 148.00M | 163.60M | 142.50M | |||
| TOTAL LIABILITIES | 168.83M | 167.97M | 160.30M | 188.20M | 168.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.05B | -1.06B | -1.08B | -1.04B | -921.00M | |||
| Additional Paid In Capital | 981.25M | 986.45M | 984.80M | 977.40M | 950.30M | |||
| Common Shares | 3.91M | 3.91M | 3.90M | 3.90M | 6.60M | |||
| Shares Outstanding | 24.95M | 26.78M | 27.40M | 27.20M | 26.30M | |||
| Tangible Book Value per Share | -4.25 | -3.89 | -4.63 | -2.20 | 1.11 | |||
| Total Shareholders' Equity | -69.47M | -66.74M | -88.10M | -56.00M | 35.90M | |||
| TOTAL LIABILITIES AND EQUITY | 99.37M | 101.23M | 72.20M | 132.20M | 204.30M | |||
| Statistics | ||||||||
| Current Ratio | 4.02 | 3.82 | 2.97 | 3.96 | 6.99 | |||
| Return On Assets (ROA) | 3.99% | 19.42% | -54.60% | -88.13% | -97.64% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -555.63% | |||
| Return On Invested Capital (ROIC) | N/A | 20.63% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 46.70% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 495.16% | N/A | N/A | N/A | |||
All data in USD